In the News

207 News Items found
A researcher working in an MSK lab
New MSK research investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on the responsible governance of artificial intelligence in oncology; studies AI-assisted biomarker assessment in lung cancer; and demonstrates a cancer-trained large language model has strong predictive value.
Carol Brown
Gynecologic surgeon Carol Brown shared information about cancer health equity during two expert panels in February.
Photo of a man, woman, and child sitting outside smiling
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Luis Alberto Diaz Jr.
President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.
an illustration of cancer metastasis
In the News
Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Mount Rushmore viewed through face-detection software.
Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.
Sara Teichholtz stands in front of the water holding her son.
Learn how noninvasive prenatal tests designed to screen for genetic abnormalities in the fetus may detect the presence of cancer in pregnant women.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Two women wearing blue MSK volunteer jackets walk smiling down a hospital hallway.
Read honest stories about the challenges of survivorship from cancer survivors — and learn how MSK continues to care for people long after treatment has ended.